+ GLP-1 in Medellín · Internal Medicine

Mounjaro, Ozempic and Wegovy in Medellín — Medically Supervised Treatment

En Neuro+ ofrecemos los tres medicamentos inyectables más avanzados y respaldados por evidencia para el manejo médico de la obesidad. Prescritos y monitoreados por el Dr. Pablo Montoya, internista especialista, dentro de un programa médico estructurado.
⚠️

These medications are not diet pills: they are state-of-the-art pharmacological treatments that require a prescription and medical supervision.

3

Medications compared

BMI ≥ 30

Candidacy criterion

Up to 22.5%

Maximum reported weight loss (Mounjaro)

+ Medical indications

Who is a candidate for injectable medications?

Medical indications

  • People with obesity (BMI ≥ 30 kg/m²)
  • People with overweight (BMI ≥ 27) + a comorbidity: diabetes, high blood pressure, dyslipidemia or sleep apnea
  • Patients who don’t want or aren’t candidates for bariatric surgery
  • Pre-operative preparation to reduce BMI before surgery

Not suitable for:

  • Personal or family history of medullary thyroid cancer
  • Multiple endocrine neoplasia type 2 (MEN2)
  • Severe chronic pancreatitis
  • Known hypersensitivity to the medication
  • Pregnancy or breastfeeding

+ Comparing the three medications

Mounjaro vs. Ozempic vs. Wegovy

Mounjaro

Tirzepatide
MechanismGLP-1 + GIP (dual)
Maximum dose15 mg/week
Average weight loss15–22.5%
Main indicationObesity / T2D
FrequencyWeekly
Key studiesSURMOUNT / SURPASS

Ozempic

Semaglutide
MechanismGLP-1
Maximum dose1 mg/week
Average weight loss5–8%
Main indicationType 2 diabetes
FrequencyWeekly
Key studiesSUSTAIN

Wegovy

Semaglutide
MechanismGLP-1
Maximum dose2.4 mg/week
Average weight loss12–15%
Main indicationObesity
FrequencyWeekly
Key studiesSTEP
🟡

Note: The best medication for each person is determined by the physician based on their full clinical profile, not just the percentage reported in studies.

+ The most advanced

Mounjaro (Tirzepatide)

MOUNJARO — TIRZEPATIDE

What is Mounjaro?

The first of its class to act on two receptors simultaneously: GLP-1 and GIP. This dual action makes it significantly more potent. The most innovative obesity medication available today.

Clinical results (SURMOUNT program)

Average weight loss15% to 22.5%
Some patientsMore than 25%
A 100 kg patient15 to 22 kg or more

Available doses

2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Always start at 2.5 mg and titrate every 4 weeks.

Pluma prellenada de Mounjaro (tirzepatida)

Is Mounjaro available in Colombia?

Yes. Availability may vary by pharmacy. Ask about availability and price when you book your appointment.

+ The best known

Ozempic (Semaglutide)

Caja de Ozempic (semaglutida) — pluma prellenada

Does Ozempic work for weight loss without diabetes?

Yes, at the physician’s discretion. Dr. Montoya may prescribe it for patients with overweight or obesity and comorbidities when it is the most suitable medication for their clinical profile.

OZEMPIC — SEMAGLUTIDE 0.5–1 mg

What is Ozempic?

Weekly injectable semaglutide (GLP-1 agonist). Developed for type 2 diabetes, but widely used at the physician’s discretion to manage obesity.

Expected results

Average weight loss5–8%
HbA1c reduction in people with diabetes~1.5%
High cardiovascular riskCV benefits

Titration

Weeks 1–4: 0.25 mg/week → Weeks 5+: 0.5 mg → If more is needed: 1 mg/week

+ Approved for obesity

Wegovy (Semaglutide 2.4 mg)

WEGOVY — SEMAGLUTIDE 2.4 mg

What is Wegovy?

Semaglutide at a 2.4 mg dose, approved specifically for the treatment of obesity in adults (FDA, EMA). The direct evolution of Ozempic: same molecule, higher dose, greater efficacy.

Clinical evidence — STEP program

STEP 1 (68 weeks)14.9% of body weight
STEP 3 (intensive program)Up to 16%
When treatment is stoppedRegained part of the weight

Titration plan (5 phases, 16 weeks)

0.25 mg → 0.5 mg → 1 mg → 1.7 mg → 2.4 mg (maintenance from week 17)

Pluma prellenada de Wegovy (semaglutida 2.4 mg)

How long does Wegovy treatment last?

It is a long-term treatment. When it is stopped, patients regain part of the weight lost. The goal is to integrate it into a sustainable health plan.

+ Structured medical program

What is the process like at Neuro+?

Evaluation consultation with Dr. Pablo Montoya

Medical history, BMI, comorbidities, background. We determine which medication is best suited to your case.

Personalized prescription with a titration plan

Adapted to your tolerance. Instructions on how to give yourself the injection at home.

Nutritional support

Coordination with the Dr. Juliana Barrero for a complementary eating plan that protects muscle mass.

Regular follow-up

Monthly or bimonthly check-ups: weight, tolerability, dose adjustment and metabolic results.

WhatsApp access

Between consultations, to answer questions and report side effects promptly.

+ We answer your questions

Frequently asked questions about Mounjaro, Ozempic and Wegovy

Which is the best weight loss medication: Mounjaro, Ozempic or Wegovy?

In terms of documented weight loss, Mounjaro is the most potent (15–22.5%), followed by Wegovy (12–15%) and Ozempic (5–8%). However, the “best” one for each person is determined by the physician based on their full clinical profile.
No. All three are prescription medications. Starting them without an evaluation can hide contraindications, cause unmonitored side effects and compromise results. At Neuro+ we ensure safe, personalized treatment.
They don’t cause physical dependence. However, like any chronic obesity treatment, stopping them without a maintenance plan can lead to partial weight regain.
Most patients notice reduced appetite in the first 2–4 weeks. Visible weight loss usually begins between the first and second month. Maximum results are reached after 9 to 18 months of continuous treatment.

They aren’t used at the same time, but they can be used in pre-operative preparation to reduce BMI before bariatric surgery, or as an alternative for patients who don’t want surgery.

+ Book today

Book your medical evaluation today

Dr. Pablo Montoya — Internal Medicine · El Poblado, Medellín